Obesity is one of the most common health conditions in the world and one of the most misunderstood. Today, it affects about 4 in 10 U.S. adults, and the numbers keep rising.
An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s, researchers report.